Effective October 6, 2014, hydrocodone combination products (HCP), such as Vicodin and Lortab, have been reclassified from Schedule III to Schedule II drugs. This means doctors can no longer phone in a prescription for HCP’s and that patients must present a written prescription to the pharmacist.
View our PDF of the HCP reclassification.
Understanding the Long-Term Effects of Opioid Use on Body and Mind
Over the past two decades, the dramatic increase in opioid prescriptions has resulted in a significant rise in their adverse health effects. Often prescribed for both acute and chronic...